A trial emulation assessed whether GLP-1RA use improves cardiovascular, kidney, and death outcomes in patients with systemic lupus erythematosus, including lupus nephritis.
Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study ...
HealthDay on MSN
CHEST: Mortality Down With GLP-1 Receptor Agonist Use in T2D, Especially in Those With OSA
Cosmo Fowler, M.D., from Emory University in Atlanta, and colleagues examined data from the TriNetX U.S. Collaborative Network to examine whether OSA modifies outcomes in patients with T2DM receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback